Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review
Nalven T, Spillane N, Schick M, Weyandt L. Diversity Inclusion in United States Opioid Pharmacological Treatment Trials: A Systematic Review. Experimental And Clinical Psychopharmacology 2021, 29: 524-538. PMID: 34242040, PMCID: PMC8511246, DOI: 10.1037/pha0000510.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidBuprenorphineHumansMethadoneNaltrexoneOpioid-Related DisordersUnited StatesConceptsOpioid use disorderPharmacological treatmentPharmacological treatment trialsTreatment trialsRandomized controlled trialsLack of subgroup analysesDiverse sampleMultiracial individualsNative Hawaiian/Other Pacific IslanderAmerican Indian/Alaska Native (AI/ANMedication typeSystematic reviewPharmacological careMarginalized backgroundsRandomized clinical trialsPreferred Reporting ItemsBlack individualsOpioidSex/genderSES indicatorsNaltrexoneSubgroup analysisClinical trialsReporting ItemsIncreased risk